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Chatterjee S, Fujiwara K, Pérez NG, Ushio-Fukai M, Fisher AB. Mecha-
nosignaling in the vasculature: emerging concepts in sensing, transduction and
physiological responses. Am J Physiol Heart Circ Physiol 308: H1451–H1462,
2015. First published April 10, 2015; doi:10.1152/ajpheart.00105.2015.—Cells are
constantly exposed to mechanical forces that play a role in modulating cellular
structure and function. The cardiovascular system experiences physical forces in
the form of shear stress and stretch associated with blood flow and contraction,
respectively. These forces are sensed by endothelial cells and cardiomyocytes and
lead to responses that control vascular and cardiac homeostasis. This was high-
lighted at the Pan American Physiological Society meeting at Iguassu Falls, Brazil,
in a symposium titled “Mechanosignaling in the Vasculature.” This symposium
presented recent research that showed the existence of a vital link between
mechanosensing and downstream redox sensitive signaling cascades. This link
helps to transduce and transmit the physical force into an observable physiological
response. The speakers showcased how mechanosensors such as ion channels,
membrane receptor kinases, adhesion molecules, and other cellular components
transduce the force via redox signals (such as reactive oxygen species and nitric
oxide) to receptors (transcription factors, growth factors, etc.). Receptor activated
pathways then lead to cellular responses including cellular proliferation, contrac-
tion, and remodeling. These responses have major relevance to the physiology and
pathophysiology of various cardiovascular diseases. Thus an understanding of the
complex series of events, from the initial sensing through the final response, is
essential for progress in this field. Overall, this symposium addressed some
important emerging concepts in the field of mechanosignaling and the eventual
pathophysiological responses.
Anrep effect; mechanotransduction; NADPH oxidase; revascularization; vascula-
ture
THIS ARTICLE is part of a collection on 1st PanAmerican
Congress of Physiological Sciences: Physiology Without
Borders. Other articles appearing in this collection, as well as
a full archive of all collections, can be found online at http://
ajpheart.physiology.org/.
Cells in vivo are constantly exposed to the physical forces
associated with their local environment. Although it was
well known that forces such as gravity and friction act on
organisms and affect their function and structure, it is only
in the last two decades that the complex processes by which
these forces are sensed by cells is becoming clear (37, 48,
55, 98). Cells and indeed cellular structures respond to
external forces in a manner similar to chemical signaling
where chemicals (ligands) bind to specific receptors on cells
and initiate cellular signaling and an eventual response (24,
26, 36). Likewise, mechanical signaling or mechanotrans-
duction involves the activation of receptors. Analogous to
chemical signaling or chemotransduction, physical forces
trigger a signaling process by which mechanical stimuli are
translated into a biochemical and eventual physiological
response (9, 16, 49, 80).
This symposium was organized to present mechanosignaling
and related issues at the session titled “Mechanosignaling in
the Vasculature: Shear stress, Endothelium and Redox Signal-
ing” at the First Pan American Physiological Conference at
Iguassu Falls in August 2014. Sponsored by the American
Physiological Society, this symposium focused on various sites
of vascular mechanotransduction in the cardiovascular system,
primarily the vascular endothelium and the cardiomyocytes
(primary sites for sensing blood flow and cardiac contractility
respectively). Another focus of this session was to highlight the
differences in long-term responses by the pulmonary and
systemic vascular beds. The content and conclusion from this
session has relevance in understanding the long-term conse-
quences of mechanosensing, specifically in the context of
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cardiovascular diseases ranging from ischemia and atheroscle-
rosis to cardiac hypertrophy.
Endothelial Mechanosensing and Redox Signaling With
Altered Shear Stress (presented by A. B. Fisher)
Physical forces can modulate cellular functions by activating
mechanosensitive pathways: the sequence of events consists of
the initial sensing of the force by mechanosensors, followed by
the onset of intracellular signaling and activation of specific
transcription factors that eventually lead to regulation of gene
and protein expression (11, 25). Among the physical forces that
play a role in biology are shear stress associated with blood
flow; indeed blood flow is well established to participate in
maintaining endothelial function and vessel wall homeostasis.
Because the endothelium by virtue of its location serves as a
dynamic interface between blood flow and the vessel wall,
sensors on endothelial cells are ideally suited to sense the shear
associated with blood flow and to transduce this physical force
into biochemical responses that help to maintain vascular
structure and tone.
For more than two decades, our group has been engaged in
understanding endothelial mechanosignaling and the complex
pathways by which shear is “sensed” and transformed into a
physiological response (9, 15, 17, 18, 65). Studies on shear
signaling have hitherto been studied with onset of shear stress
where endothelial cells (EC) in culture grown under zero shear
stress conditions (i.e., in static cell culture) are subjected to
sudden onset of flow. We reversed this paradigm and investi-
gated shear signaling from the point of removal of shear; we
reasoned that this being physiologically similar to vascular
obstruction or ischemia is more relevant to an in vivo condi-
tion. However, ischemia in vivo does not merely affect the
alteration of the mechanical component of blood flow but also
causes compromised oxygen delivery to tissue. To study al-
tered blood flow (while avoiding the effects of altered oxygen
supply), we established an in situ model of pulmonary isch-
emia using a rodent isolated perfused lung (2, 82). The lung
provided a methodological advantage over other organs since
ventilation of the lung allows oxygenation of cells in the
absence of blood flow. In our experiments with stopped flow in
isolated perfused lungs, the tissue pO2 values remained con-
stant (pO2*140 mmHg), and there was no decline in ATP
levels. This model thus enabled us to study the effects of the
loss of the mechanical component of flow alone without the
effects of tissue hypoxia.
Using this isolated perfused model, we observed that abrupt
cessation of flow caused the production of reactive oxygen
species (ROS) that occurred by via activation of endothelial
cell NADPH oxidase (Nox2) (4, 33, 97). The NADPH oxidase
(Nox) family consists of 7 members with different catalytic
subunits termed Nox1-5 and Duox1 and Duox2 (for Dual
Oxidase); regulatory subunits p22phox, p47phox, Noxo1,
p67phox, Noxa1, p40phox; and the major binding partner Rac
1 or 2 and the membrane subunit gp91phox. Nox1, 2, 4, and 5
enzymes are expressed in cardiovascular tissues (54). Of these,
Nox2 has traditionally been described as responsible for the
respiratory burst in phagocytes and is now accepted to be a
vascular oxidase. Nox2 was found by us to be activated with
stop of flow (15, 97). On activation, Nox2 uses NADPH to
reduce molecular oxygen to superoxide anion, which dismu-
tates to H2O2 (53, 54).
Using the H2O2 sensitive dye dichlolorodifluorofluorescein
diacetate (H2DCFDA) or its carboxy-fluorinated derivative
difluorofluorescein diacetate (H2DFFDA), which was perfused
through the isolated lungs, we observed increased fluorescence
(DCF or DFF) with stopped flow. DCF/DFF fluorescence was
significantly reduced in lungs from mice with knockout of
Nox2 (gp91phox subunit) or wild-type lungs pretreated with
catalase or the nonspecific NADPH oxidase inhibitor, diphe-
nyleneiodonium (15, 65, 97).
The earliest event in shear sensing had been reported else-
where to be a K1 channel. Indeed, onset of flow was observed
to cause hyperpolarization via opening of this channel (66). We
posited that these channels that are activated by shear could
also be closed by removal of the shear stimulus. We selected
membrane potential sensitive dyes (di-8-ANEPPS and bisox-
onol) that increase fluorescence in a depolarized membrane to
assess channel activation with stop of flow (1, 82). Isolated
lungs labeled with these dyes showed an increased fluores-
cence almost immediately upon stop of perfusate flow. Depo-
larization could be blocked by pretreating isolated lungs with
the KATP channel opener (agonist) cromakalim; in the presence
of flow, depolarization could be attained by the KATP channel
blocker (antagonist) glybenclamide (1, 3, 14). Thus we pro-
posed that a KATP channel of lung endothelium is responsible
for maintaining membrane potential with normal shear and is
inactivated by loss of shear leading to endothelial membrane
depolarization as a key component in the cell signaling cas-
cade.
The KATP channel consists of an inwardly rectified K1
channel pore (KIR6.x) and a regulatory subunit the sulfonylurea
receptor (SUR) (8, 10). The KATP channel was observed to be
induced in pulmonary microvascular endothelial cells by flow
(14). Using in vitro flow systems where endothelial cells were
subjected to various periods of flow, we reported that both
components of the channel were very low in cells cultured
under static conditions but increased during exposure to 24–48
h of flow. KIR currents (as measured by patch clamp) too were
low in static cells and increased after adaptation to flow. Real
time measurements of KIR currents showed that these currents
were shear sensitive, i.e., flow-adapted cells showed character-
istics of an activated KIR channel (high inward rectifier cur-
rents) under flow that decreased significantly with stop of flow
(14, 17).
Induction of the KATP channel by flow suggested to us the
presence of a shear responsive element on the endothelium that
is upstream and independent of the channel. A cell surface
entity would be well suited to be a primary transducer. Based
on previous studies on transduction of mechanical forces in-
cluding shear stress by a mechanosensory complex including
platelet endothelial cell adhesion molecule 1 (PECAM-1) (86)
and on reports of PECAM-1 activation (tyrosine phosphoryla-
tion) upon flow (22) we investigated whether PECAM-1 could,
by virtue of its junctional location and cytoskeletal linkage,
serve as a mechanosensor for the loss of blood flow. Our
investigations revealed that lack of PECAM (PECAM-1 null
mice lungs) markedly reduced the response to stop of flow (in
terms of ROS production) by the pulmonary endothelium.
Immunolabeling of lung sections showed that most of the
cellular PECAM (70%) was located in caveolae (65). We had
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shown earlier that caveolin-1 and (and thus caveolae) partici-
pated in the stop of flow response (65).
We thus concluded that a PECAM-caveolae mechanosens-
ing complex on the endothelium is able to sense the changes in
membrane tension with stop of flow. A multimeric complex
comprising PECAM-1, vascular endothelial growth factor
(VEGFR2), and vascular endothelial (VE)-cadherin has been
reported to be sufficient to confer responsiveness to shear stress
in cells. Taken together, we posit a mechanosome hypothesis,
i.e., a network of mechanosensors and transducers that transmit
a physical force into biochemical and transcriptional activity
that can alter cellular structure and function. We conclude that
the mechanosome on the endothelial cell membrane consists of
caveolae, PECAM, VEGFR2, and VE-cadherin (and possibly
other elements). The mechanosome senses changes in mem-
brane tension resulting in the deactivation of KATP channels
(15). The altered membrane potential results in the activation
of Nox2 and eNOS with consequent production of ROS and
nitric oxide (NO) (18) (Fig. 1). ROS is a signal for activation
of transcription factors such as hypoxia inducible factor (HIF-
1a), NF-kB, and activating protein-1 (AP-1), which reportedly
drive revascularization with the homeostatic purpose to restore
impeded flow (9).
Mechanism of PECAM-1 Mechanotransduction in
Endothelial Cells (presented by K. Fujiwara)
ECs by virtue of their location are uniquely situated to face
the physical force associated with blood flow. Shear regulates
EC morphology, biosynthetic activity, and gene expression
indicating that ECs possess flow sensing machinery that senses
and responds to blood flow (21, 28, 41). Thus ECs are consid-
ered as a model system to study cellular mechanobiology;
indeed studies using ECs have revealed that the mechanore-
sponse by endothelium triggers signaling that has important
implications in the context of the pathophysiology of cardio-
vascular diseases. For instance, atherosclerosis, a focalized
vascular disease caused by a combination of many risk factors,
has been observed to be dependent on patterns of blood flow.
Atherosclerotic plaques develop in regions where nonlaminar,
disturbed blood flow occurs, such as branches, bifurcations,
and curvatures of large arteries (28, 41). Besides disturbed
flow, stretch patterns in these regions are not uniaxial, i.e., they
are not along a single axis; thus both disturbed flow and
non-uniaxial stretch are recognized to be pro-atherogenic me-
chanical forces (21, 83). As it is practically impossible to
locally alter the flow patterns associated mechanical forces
within blood vessels, a more reasonable approach to control-
ling atherogenesis would be to regulate EC responses to these
mechanical forces. To do so, the processes by which mecha-
nosensing by ECs occurs, must be understood.
The major challenge in studying mechanosensing moieties is
that unlike chemo receptors that can be identified based on
their binding to specific ligands, and thus purified, cloned, and
studied using biochemical and other analytical means, mecha-
noreceptors cannot be easily identified as they have no ligand
equivalent. We thus have to focus on the downstream events
that occur post flow and flow sensing to obtain information on
the earliest mechanosensing events. Such studies show that
ECs are equipped with machinery for sensing mechanical
forces, although the entities or moieties (often referred to as
mechanosensors) that sense flow are numerous and varied.
Analogous to a ligand receptor, a mechanosensor is the first
thing that mechanical forces act on and has the ability to
convert a mechanical stimulus into a biochemical reaction that
can induce mechano-dependent cellular responses.
Candidate mechanosensors are the glycocalyx (34, 69), pri-
mary cilia (61, 62), caveolae (9, 10), focal adhesions/integrins
(78, 95), ion channels (28, 60), trimeric G proteins (40, 52),
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Fig. 1. Schematic of the mechanotransduc-
tion cascade in pulmonary vascular endo-
thelium with stop of flow. Flow sensing by
endothelial cells occurs via the mechano-
some complex composed of caveolae-
PECAM, VEGFR2, and VE-cadherin and
possibly other elements resulting in deac-
tivation of KATP channel. This alteration in
membrane potential results in activation of
NOX2 and endothelial nitric oxide (NO)
synthase (eNOS) with consequent produc-
tion of reactive oxygen species (ROS) and
NO. These mediators result in vasodilation
and neovascularization as an attempt to
restore the impeded blood flow (modified
from Ref. 16). HIF-1a, hypoxia inducible
factor-1a; AP-1, activating protein-1.
Review
H1453MECHANOTRANSDUCTION AND REDOX SIGNALS
AJP-Heart Circ Physiol • doi:10.1152/ajpheart.00105.2015 • www.ajpheart.org
Downloaded from journals.physiology.org/journal/ajpheart (163.010.250.070) on September 29, 2020.
nuclei (32), and PECAM-1 (35). It is possible that all of them
are, in some way, involved in EC mechanosignaling, but are
they sensors? The general consensus is that there is not a single
mechanosensor but several which work in concert, possibly as
a series of multimeric complexes.
For more than a decade, our laboratory has investigated
PECAM-1-dependent signaling pathways initiated by shear
stress. PECAM, a glycoprotein expressed in ECs, platelets,
and leukocytes (63), is by virtue of its junctional location
and cytoskeletal linkage well suited to be a mechanosensor.
In solitary ECs, it is diffusely distributed in the plasma
membrane but when cultured ECs make contacts, PECAM-1
aligns at the contact site. This alignment occurs in 2 to 4 h,
unlike other contact adhesion molecules such as VE-cad-
herin, which do so almost immediately (7). This suggests
that homophilic binding of PECAM-1 is not essential for
cell-cell contact formation and may have some other func-
tions. In vivo, PECAM-1 has several other functions,
namely a role in leukocyte trafficking across the endothe-
lium (63), regulation of certain integrin activities (20, 64)
[flow-activated integrin activities are PECAM-1 dependent
(21)], and interaction with the actin cytoskeleton via b- and
g-catenins (45, 47) and/or by vimentin (27, 46).
PECAM-1 has been observed to respond to shear or stretch
on the endothelial surface by phosphorylation of a tyrosine
(Tyr) residue. Indeed, when ECs in a confluent monolayer
(instead of a sparse culture) were exposed to physiological
levels of shear stress (67) or cyclic stretch (22), PECAM-1 was
rapidly Tyr phosphorylated. Tyr phosphorylation of PECAM-1
was also observed with hypo- or hyper-osmotic shock (67),
another form of mechanical perturbation. Postphosphorylation
PECAM-1 binds to SHP-2 (57), a protein tyrosine phosphatase
involved in ERK1/2 activation. Because ERK1/2 is activated
by flow (85) and stretch (81) in ECs, this activation may
depend on PECAM-1 phosphorylation and subsequent binding
to SHP-2 (67). SHP-2 is a cytoplasmic protein, but shortly after
ECs are challenged with mechanical stresses, SHP-2 is re-
cruited to the cell-cell contact region where PECAM-1 is
localized (67). SHP-2 accumulation at cell contacts is a good
readout for observing PECAM-1 activation in ECs (Fig. 2A).
With use of SHP-2 as a reporter for PECAM-1 phosphoryla-
tion, mechanical force-induced phosphorylation of PECAM-1
inside cells was visualized. When ECs were hyperosmotically
shocked, PECAM-1 phosphorylation occurred all around cells
while laminar flow activated PECAM-1 signaling at the cell
border oriented perpendicular to the direction of flow (Fig. 2B).
The flow data suggest that PECAM-1 mechanosignaling is
initiated locally, not globally, in a cell.
We reasoned that if PECAM-1 was indeed mechanorespon-
sive, we may be able to achieve its phosphorylation and
downstream signaling by directly pulling on the molecule. To
test this, magnetic beads coated with antibodies against the
PECAM-1 external domain were attached to the surface of
sparsely cultured ECs and pulled by placing a strong magnet
over the cells (67). Cell homogenates were assessed for
Tyr-phosphorylation, which was detected only when PE-
CAM-1 bound to beads which had been pulled by a magnet.
In addition, ERK1/2 was activated when PECAM-1 was
pulled by magnetic beads. Although these results suggest that
PECAM-1 signaling can be induced in ECs by applying force
directly to PECAM-1, it is possible that this phosphorylation is
caused by other moieties associated with the plasma membrane
(such as ion channel activation) and/or cytosolic proteins,
which are activated by pulling on PECAM-1. To evaluate these
possibilities, we made a cell model by extracting a monolayer
of ECs with a detergent containing solution, which was then
stretched in the presence of ATP (22). Under these conditions,
PECAM-1 was phosphorylated. Using this system, we identi-
fied Fyn kinase (which presumably was associated with the cell
model) as the PECAM-1 kinase. Because PECAM-1 phosphor-
ylation occurs by stretching lifeless cell models (that have no
cytoplasmic soluble milieu and ionic events involving the
plasma membrane), we have concluded that PECAM-1 phos-
phorylation can be mechanically triggered.
PECAM-1 null mice (29, 56) show no adverse phenotype,
but Schenkel et al. subsequently showed that the genetic
background of mice against which the PECAM-1 null condi-
tion was imposed played a major role in the severity of
defective phenotypes (79). There are several lines of evidence
that tie PECAM-1 to cardiovascular diseases. It has an anti-
inflammatory effect (75), and neointima formation seen in the
carotid ligation model depends on PECAM-1 expression (19).
When PECAM-1 null mice were crossed with ApoE null mice,
reduced atherosclerosis was noted (42), whereas another study
found both pro-atherogenic and athero-protective effects of
PECAM-1 depending on the vessel types studied (38). There
are several known PECAM-1 polymorphisms in the human
that have a positive correlation with cardiovascular diseases
(30, 31, 39). These recent developments beg for a closer look
at the role of PECAM-1 in cardiovascular diseases as well as
for further mechanistic studies on the workings of PECAM-1
signaling.
The Anrep Effect: A Redox-Sensitive Phenomenon (presented
by N. G. Pérez)
The contractile apparatus of the heart is modulated by potent
intrinsic mechanisms in the cardiac muscle that allow for
adapting cardiac output to hemodynamic changes; that is, a
sudden increase in cardiac muscle length immediately leads to
a more powerful contraction. This is termed the Frank-Starling
mechanism and describes how stretch of the cardiac muscle
increases contractility. The cellular mechanism underlying the
Frank-Starling response is an increase in myofilament sensi-
tivity for Ca21. This allows the heart to increase its output
after a rise in preload or to maintain it despite a greater
afterload. It also links cardiac ejection (arising from con-
tractility) to cardiac filling (arising from expansion). Inter-
estingly, after this initial rise in contractility myocardial
performance slowly continues to increase, reaching a new
steady state over the next 10 –15 min.
Gleb von Anrep was the first to observe this phenomenon
more than a century ago in a whole heart preparation (93) when
he observed that clamping the ascending aorta in a dog (acutely
decreasing outflow and increasing intraventricular pressures)
caused an initial dilation of the heart; however, it progressively
returned toward its previous end-diastolic volume unveiling a
positive inotropic effect. Several years later the presence of a
second slow component of increase in force following a change
in cardiac muscle length was found in an isolated cardiac
preparation by Parmley and Chuck (70). Afterward, Allen and
Kurihara (5) demonstrated that this slow phase was due to a
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progressive increase in the intracellular calcium transient am-
plitude. Currently, the term “slow force response” (SFR) to
stretch is widely accepted to identify this in vitro equivalent to
the “Anrep phenomenon.”
During the last two decades, our laboratory has focused on
the signaling pathways that generate the SFR. We have ob-
tained evidence to propose that the SFR is the mechanical
expression of a stretch-triggered autocrine/paracrine loop of
intracellular signals that involves an increased production of
ROS, activation of the redox-sensitive kinase cascade of MEK-
ERK1/2-p90RSK, and the consequent phosphorylation (acti-
vation) of the cardiac Na1/H1 exchanger (NHE1) (for review
see Ref. 23).
The increased production of ROS is a crucial step in the
mechanism leading to the SFR generation. Conversely,
suppression of ROS production blunts the SFR (13). These
ROS are from mitochondrial origin but induced by a small
amount of NADPH oxidase (NOX)-derived ROS, in a way
that may be analogous to the so-called “ROS-induced ROS-
release” phenomenon described by Zorov et al. (99) years
ago and shown more recently in pulmonary microvascular
endothelial cells (43). The complete sequence of events
triggered by myocardial stretch and leading to the Anrep
Effect is schematized in Fig. 3 and comprises the 1) release
of the pro-hypertrophic factors angiotensin II and endothelin
with the consequent sequential activation of their respective
receptors (AT1-ETA), 2) activation of the mineralocorticoid
receptor (MR), 3) transactivation of the epidermal growth
factor receptor, 4) NOX activation (that may also occur in
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Fig. 2. A: bovine aortic endothelial cells (ECs) were transfected with platelet endothelial cell adhesion molecule 1 (PECAM-1) short interfering RNA (siRNA),
treated with hyperosmotic shock (HOS) or without hyperosmotic shock (No HOS) for 2 min (a condition known to induce PECAM-1 phosphorylation), and
double-stained with anti-PECAM-1 (top) and anti-SHP-2 (bottom). The same field of view is shown for PECAM-1 and SHP-2. Top: several adjacent cells that
were not transfected with the siRNA (thus expressing PECAM-1 at their shared cell border; arrows). When such cells were shocked with hyperosmotic medium
(HOS), PECAM-1 became phosphorylated, which can be visualized by anti-SHP-2 staining (bottom left). Unshocked cells do not show cell border staining with
anti-SHP-2 (right). These images demonstrate that SHP-2 relocalization can be used as a PECAM-1 phosphorylation reporter in ECs. Note that SHP-2 is normally
localized throughout the cell. Data provided by Dr. Elena McBeath. B: SHP-2 relocalization to cell-cell contacts in confluent bovine aortic ECs. Anti-SHP-2
staining in unstimulated cells (static) show little cell border associated fluorescence. When ECs were exposed to 1 Pa of laminar shear stress for 5 min (flow),
short linear anti-SHP-2 staining associated with cell border can be detected. Some of the stained areas are highlighted by straight lines (roughly 10 mm long).
Note that many lines are roughly perpendicular to flow direction (arrow). Five minutes of hypersomotic shock (HOS), which is thought to cause membrane
perturbation more equally throughout the entire cell border, causes extensive cell border staining, which surrounds the entire cell. Data provided by Brooke
Krovic and Elena Mcbeath.
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production, 6) activation of redox-sensitive kinases, 7)
NHE1 hyperactivity, 8) increase in intracellular Na1 con-
centration, 9) increase in Ca21 transient amplitude through
the Na1/Ca21 exchanger in reverse, and 10) development of
the Anrep Effect or SFR.
Physiologically, the Anrep Effect constitutes a powerful
mechanism by which the heart adapts to an abrupt increase in
afterload, occurring just after the Frank-Starling mechanism
takes place. Interestingly, crucial intracellular signals for the
development of the Anrep Effect like increased oxidative
stress, NHE1 hyperactivity, and augmented Ca21 concen-
tration were reported to play critical roles in the progression
of pathological cardiac hypertrophy (for review see Refs. 92
and 94).
In this context, it is attractive to hypothesize that mechan-
ical stress may not only trigger immediate intrinsic heart
mechanisms to adapt cardiac output to changes in hemody-
namic conditions (Anrep phenomenon), but also would
constitute the first step toward cardiac hypertrophy and
eventually heart failure if the initial events are sustained
over time. In this regard, and from a clinical point of view,
we are tempted to affirm that among the latest contributions
of our group to elucidate the mechanism leading to the SFR,
the finding of the crucial role played by the MR was
probably the most important one (12, 71). This may provide
a reasonable explanation to the remarkably beneficial effects
of MR antagonists in the treatment of patients with cardiac
hypertrophy and failure (73, 74, 96), and encourage us to
suggest that prevention of oxidative stress and NHE1 acti-
vation should be considered as potential key factors to reach
this salutary effect.
Stop of Blood Flow Drives Neovascularization Via Reactive
Oxygen Species-Induced Recruitment of Bone Marrow Stem
Cells (presented by M. Ushio-Fukai)
Stop of blood flow or ischemia has been reported to drive
neovascularization. In the case of ischemic heart and peripheral
artery diseases, where blood flow is stopped or compromised,
neovascularization is critical in eventual restoration of blood
flow. Indeed treatment strategies are focused on accelerating
processes that restore impeded blood flow. Restoration or
reinstatement of flow depends on angiogenesis that occurs as
stem and progenitor cells released from the bone marrow (BM)
home into regions of ischemia and promote blood vessel
growth. The difference between stem cells and progenitor cells
is that while the former exhibit multipotency or pluripotency
and the capacity for self-renewal, and clonal expandability, the
latter, although possessing their self-renewal capacity, are
committed to selected lineages. Although both BM stem and
BM progenitor cells have been used for regenerative therapies,
their reduced angiogenic and regenerative function under path-
ological conditions such as aging and diabetes mitigate their
regenerative function. Thus identifying the key factors that can
regulate their regenerative function would be of great value for
therapeutic applications of stem/progenitor cells.
The stem/progenitor cells in BM are distributed in distinct
microenvironments also called niches, such as the stromal
niche, the endothelial niche, and niches in the extracellular
matrix (59). Undifferentiated hematopoietic stem cells that
reside within the BM niche are maintained in a quiescent state.
With stimulation, these quiescent cells can undergo prolifera-
tion, migration, and differentiation. With ischemia, the BM
niche is regulated such that stem and progenitor cell function
Fig. 3. Signaling pathway triggered by myocardial
stretch leading to Anrep Effect or slow force response
(SFR). To better appreciate the development of the SFR
after the initial increase in force following myocardial
stretch, an original force record of an isolated papillary
muscle stretched suddenly from 92% to 98% of its
maximal length is included at the bottom of the figure.
ET, endothelin; ALD, aldosterone; TSA, transactiva-
tion; mKATP, mitochondrial ATP-sensitive potassium
channel; MPTP, mitochondrial permeability transition
pore; EGFR, epidermal growth factor receptor; MR,
mineralocorticoid receptor; NCX, Na1/Ca21 ex-
changer. See text for details and other abbreviations.
Review
H1456 MECHANOTRANSDUCTION AND REDOX SIGNALS
AJP-Heart Circ Physiol • doi:10.1152/ajpheart.00105.2015 • www.ajpheart.org
Downloaded from journals.physiology.org/journal/ajpheart (163.010.250.070) on September 29, 2020.
and activity are affected. This is because ischemia associated
injury causes an increase in cytokines and growth factors such
as VEGF in BM and in the circulation. Cytokines and VEGF
activate matrix metalloproteinase (MMP-9) and release soluble
kit ligand in the BM microenvironment (77). MMP-9, which is
secreted mainly by neutrophils in BM (68), and MT1-MMP
(Membrane Type 1 MMP) (50), which is anchored on the cell
surface, affect stem/progenitor cell mobilization and thus drive
angiogenesis. Our laboratory is focused on understanding how
ischemia regulates the BM niches and thus stem/progenitor cell
function as this is critical in the development of novel thera-
peutic strategies to enhance regeneration of diseased tissues.
Recent evidence from our laboratory shows that ROS such
as superoxide anion (O2·2) and hydrogen peroxide (H2O2) can
determine stem/progenitor cell function (89, 91). Induction of
ROS in stem cells is regulated by various factors such as
cytokines, growth factors, hypoxia, etc. Studies show that ROS
levels in BM stem and progenitor cells correlate with their
function and differentiation. ROShigh cells show higher differ-
entiation while ROSlow cells show greater capacity for self-
renewal (51). BM niches include hypoxic or normoxic (less
hypoxia) niches. Because oxygen is required for production of
ROS, hynoxic niches exhibit low ROS levels as compared with
normoxic niches (89). Overall, the state of the cells and their
micro environment is critical for determining stem and pro-
genitor cell fate and function (44, 89). One of the major sources
of ROS involved in BM niche signaling is the enzyme NADPH
oxidase 2 (Nox2). Nox 2 is expressed in phagocytes and
nonphagocytic cells including stem/progenitor cells (89, 91)
and differentiated myeloid cells such as neutrophils and mono-
cytes/macrophages. These cells generate O2·2 via activation of
Nox2 (also known as gp91phox, the membrane subunit of the
NADPH oxidase complex). Nox isoforms expressed in stem/
progenitor cells (72) and Nox-derived ROS are involved in
differentiation, proliferation, senescence, or apoptosis (89, 90).
Under conditions of oxidative stress BM niches or environment
may have excess amounts of ROS, which can induce apoptosis
of stem and progenitor cells (89).
Using a model of hindlimb ischemia (in wild-type and
Nox22/2 mice), we demonstrated that stop of blood flow to the
femoral artery increases Nox2-dependent ROS production in
BM-derived mononuclear cells (BMCs). We also showed that
postischemic neovascularization and mobilization of BM pro-
genitor cells are impaired in Nox22/2 mice (84, 87). Injection
of wild-type BMCs, but not Nox22/2 BMCs, enhanced angio-
genesis in the limb (as evidenced by increased perfusion) after
Fig. 4. A: Nox2 is involved in superoxide
(O2·2) production in bone marrow (BM) in
situ in response to hindlimb ischemia. Rep-
resentative images of O2·2 production in BM
of femur from wild-type (WT) or Nox2
knockout (KO) mice subjected to hindlimb
ischemia [1ischemia (day 3)] or without
hindlimb ischemia (control). To detect O2·2
in situ, dihydroethidium (DHE) was injected
60 min before tissue harvest. Long bone
surface is shown by dotted lines. Bottom:
hindlimb ischemia increases hypoxic area in
BM, in a Nox2-dependent manner. Mice
were injected with pimonidazole 3 h before
euthanization. Femur sections from mice
subjected to hindlimb ischemia [1ischemia
(day 3)] or without ischemia (control) were
stained with anti-pimonidazole antibody
(green) and 4=,6-diamidino-2-phenylindole
(DAPI) to visualize nuclei (blue). Bars show
100 mm. Bone (B), endosteal (E) (defined as
50 mm apart from the bone surface), and
central (C) regions are indicated. B: Nox2
regulates BM microenvironment involved in
progenitor cell function and mobilization in
response to ischemia. After ischemic injury,
ROS production is increased in entire BM in
a Nox2-dependent manner, which is required
for increasing hypoxic niche and its down-
stream HIF-1a and VEGF expression in
BM. Nox2-derived ROS also increase Akt
phosphorylation and its downstream mem-
brane type1-matrix metalloproteinase (MT1-
MMP) expression and MMP-9 activity in
BM. It is possible that ROS and Akt pathway
are involved in HIF-1a expression through
hypoxia-independent mechanism (dotted ar-
rows). These Nox2-dependent alterations of
BM microenvironment promote progenitor
cell survival and expansion, thereby promot-
ing their mobilization, leading to reparative
neovascularization and tissue repair (modi-
fied from Ref. 88).
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Fig. 5. KATP channel in flow sensing in vitro and in vivo. A: KIR currents decrease with stop of shear. Inward rectifying whole cell K currents (KIR) were measured
in mouse pulmonary microvascular endothelial cells (PMVEC). i: voltage protocol is shown above the experimental tracings. ii and iii: representative recordings
obtained from flow-adapted pulmonary microvascular endothelial cells of wild-type and KIR 6.2 null mice. Current measurement from a single (ii) wild-type cell
and (iii) KIR6.22/2 cell, during flow and with stop of flow. The currents recorded are the inwardly rectifying K1 currents (KIR). The flow protocol generated an
estimated shear stress of 2 dynes/cm2. Stop flow indicates recording immediately following the abrupt cessation of flow. B: KATP channel-dependent
revascularization in vivo. Stop of flow in vivo was studied using a hindlimb ischemia model. The femoral artery was ligated, and the region between the ligatures
is excised and photographed (a–d) or imaged (e and f) by confocal microscopy. For e and f, fluorescent microbeads (40 nm) injected into the aorta were used
to visualize microvessels in the region distal to the vascular obstruction (modified from Refs. 9 and 17).
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ischemia (87). Moreover, in vivo injection of O2·2 reactive dye
into wild-type and Nox22/2 mice before euthanasia demon-
strated that Nox2-dependent ROS production is markedly in-
creased in entire BM following ischemic injury (88). We found
that ischemia induced alteration of the BM microenvironment
was Nox2 dependent and occurred via VEGF expression and
Akt phosphorylation as also via MT1-MMP expression and
MMP-9 activity in BM tissue (88). Furthermore, these ROS-
mediated, hypoxic BM microenvironment alterations induced
by ischemia regulate progenitor cell survival and expansion,
thereby promoting their mobilization from BM (89) (Fig. 4).
Thus our study suggests that Nox2-derived ROS play an
important role in redox regulation of the BM microenviron-
ment, thereby promoting progenitor cell function and mobili-
zation that is required for enhancing postnatal neovasculariza-
tion and tissue repair in response to injury.
Mechanosensing Drives Neovascularization in vivo That is
KATP Channel Dependent (presented by S. Chatterjee)
It is now well established that mechanotransduction by the
endothelium associated with shear stress arising from luminal
blood flow is transduced to signals that help to maintain
vascular function and homeostasis (6, 76).
Our research showed that stop of flow caused KATP channel
closure (Fig. 5A) that led to ROS production, and this ROS
caused endothelial cell proliferation (9, 58). Does this prolif-
eration lead to remodeling or is it a nonpurposeful response?
To answer this question, we assessed if the KATP-dependent
mode of Nox2 activation had any relevance to vascular remod-
eling. Using in vitro (Matrigel coated dishes) and in situ
(Matrigel plug in nude mice) models, we found that the
postischemia angiogenic potential of wild-type endothelial
cells was significantly higher than that for KATP channel null
and Nox2 null cells (9). The implications of proliferation and
angiogenesis were clear when we assessed the effect of stopped
flow in vivo using a model of systemic ischemia, i.e., femoral
artery ligation. To achieve this, we did not cut or excise the
femoral vessel but merely tied it; we reasoned that this ap-
proach would minimize the injury arising from the experimen-
tal procedure and would limit the complex signaling cascade
activated by inflammation and tissue damage.
Wild-type mice showed revascularization 5 days post fem-
oral artery ligation, whereas mice with knockout of the KATP
channel (i.e., the KIR6.2 subunit of the channel) or of Nox2
showed less revascularization post ischemia (Fig. 5B). Revas-
cularization postischemia also was compromised in mice fed
with the KATP agonist cromakalim or the NADPH oxidase
inhibitor apocynin, as well as in mice where the channel
function was compromised by a genetic approach (SUR12/2,
deletion of the SUR subunit is reported to compromise KATP
channel function) (9). Blocking or deletion of other elements of
the cascade (PECAM-12/2 and Akt-12/2 that do not produce
ROS with ischemia) resulted in less revascularization as com-
pared with wild-type mice. We concluded that KATP-channel
induced Nox2 activation and subsequent ROS production
drives revascularization in this hindlimb model. Nox2 is ex-
pressed in several cell types including endothelial cells, bone
marrow-derived cells, and inflammatory cells (such as neutro-
phils, macrophages, etc.) and Nox2 in bone marrow-derived
cells was involved in the vascular remodeling (88). To assess
this role of endothelial Nox2, we studied endothelial targeted
Nox2 expressing mice (endoNox2Tg) in which Nox2 is ex-
pressed only in endothelium (9). Revascularization in these
mice was somewhat intermediate between wild-type and either
Nox2 or KATP null mice, indicating a role for endothelial Nox2
in revascularization. Although endothelial Nox2 generated
driven ROS is important, it does not play an exclusive role in
vascular remodeling (9).
We discovered that the initiating signal for revascularization
postischemia was dependent on HIF-1a and VEGF, based on
Nox2-dependent regulation of HIF-1a and VEGF expression.
The evidence for VEGF dependence was revascularization in
the hind limb was seen only in those mouse models that
showed increased VEGF expression and revascularization
could be restored in the null phenotype (KATP null, i.e., KIR6.2
null) by delivery of VEGF into the ischemic region postliga-
tion.
Based on our results, we conclude that mechanotransduction
via the KATP channel drives vascular remodeling via ROS
generation by endothelial and other cells that subsequently
increases VEGF and HIF-1a production. Thus the biochemical
response to altered flow generates a signal for growth of
collateral vessels and represents an attempt at revascularization
to restore the impeded blood flow (16).
In summary, the symposium presentations reflected the
novel insights into complexity of mechanotransduction in var-
ious systems ranging from the vasculature to the cardiac
contractility apparatus, the overarching commonality being the
role of Nox2-derived ROS in the transmission and transduction
of the mechanosignal into a physiological or pathophysiolog-
ical response. The main conclusions from these presentations
are 1) PECAM-1 is an important component of the mechano-
sensing complex that senses altered mechanical forces; 2)
activation of enzymes (primarily Nox2) that generate ROS play
a key role in the propagation on the mechanically induced
signal; 3) other key components of the mechanosignaling
cascade include ion channels and intracellular kinases that
serve as important links between induction of the signal and the
physiological response; and 4) an altered mechanotransduction
provokes a broad range of physiological and pathophysiolog-
ical responses.
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